MedTrace Logo

Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude

NCT02352298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-06-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the performance of the Dario Blood Glucose Monitor (BGMS), at elevated altitudes, by obtaining whole blood fingerstick samples from individuals and analyzing the blood on the Dario Blood Glucose Monitor (BGMS) and comparing the readings to readings obtained from the YSI 2300 STAT Plus glucose analyzer.

Conditions

Interventions

DEVICE

Dario Blood Glucose Monitoring System

Fingerstick to obtain blood sample for analysis with the Dario BGMS

DEVICE

YSI Analyzer

Fingerstick to obtain blood sample for analysis with YSI

Sponsors & Collaborators

  • LabStyle Innovations Ltd.

    lead INDUSTRY

Principal Investigators

  • Christie Beatson · Barbara Davis Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02352298 on ClinicalTrials.gov